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Abstract
Background: The objective of this meta-analysis was to compare the clinical and oncologic outcomes of robotic
low anterior resection (R-LAR) with conventional laparoscopic low anterior resection (L-LAR).
Methods: A search in the MEDLINE, Embase, and Ovid databases was performed for studies published before July
2014 that compared the clinical and oncologic outcomes of R-LAR and L-LAR. The methodological quality of the
selected studies was assessed. Depending on statistical heterogeneity, a fixed or random effects model was used
for the meta-analysis. The clinical and oncologic outcomes evaluated included operative time, estimated blood loss,
length of hospital stay, rate of conversion to open surgery, post-operative complications, circumferential margin
status, and number of lymph nodes collected.
Results: Eight studies, including 324 R-LAR cases and 268 conventional L-LAR cases, were analyzed. The meta-
analysis showed that R-LAR was associated with a shorter hospital stay (mean difference (MD) = −1.03; 95 %
confidence interval (CI) = −1.78, −0.28; P = 0.007), lower conversion rate (odds ratio (OR) = 0.08; 95 % CI = 0.02, 0.31;
P = 0.0002), lower rate of circumferential margin involvement (OR = 0.5; 95 % CI = 0.25, 1.01; P = 0.05), and lower
overall complication rate (MD = 0.65; 95 % CI = 0.43, 0.99; P = 0.04) compared with L-LAR. There was no difference in
operative time (MD = 28.4; 95 % CI = −3.48, 60.27; P = 0.08), the number of lymph nodes removed (MD = −0.63;
95 % CI = −0.78, 2.05; P = 0.38), and days to return of bowel function (MD = −0.15; 95 % CI = −0.37, 0.06; P = 0.17).
Conclusions: R-LAR was shown to be associated with a shorter hospital stay, lower conversion rate, lower rate of
circumferential margin involvement, and lower overall complication rate compared with L-LAR. There were no
differences in operative time, the number of lymph nodes removed, and days to return of bowel function.
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Background
Laparoscopic colorectal resection has been popularized
due to its associated short length of hospital stay, reduced
post-operative pain, and early return to normal bowel
function [1, 2]; however, the laparoscopic colorectal tech-
nique has several drawbacks, such as a two-dimensional
view and the limited dexterity of instruments due to the
fixed instrument tips [3]. The da Vinci Surgical System
was first used by colorectal surgeons in 2002 and was
shown to overcome the drawbacks of conventional laparo-
scopic surgery. The da Vinci Surgical System allows for
improved dexterity of movement, 3D and magnified vi-
sion, and tremor filtering [4]. Both laparoscopic and
robotic surgeries for rectal cancer have been proven to be
safe and effective. Thus far, there have been several studies
comparing the clinical and oncologic outcomes of robotic
versus laparoscopic surgery for rectal cancer [5–7], but
few studies and no meta-analyses have been conducted
comparing the outcomes of robotic (R-LAR) versus lap-
aroscopic low anterior resection (L-LAR).
Methods
Information sources and search
A search in the MEDLINE, Embase, and Ovid databases
was performed for studies published before July 2014
comparing clinical or oncologic outcomes of R-LAR and
L-LAR. In addition, the abstracts published at major inter-
national conferences were manually searched. The follow-
ing search terms were used: “robotic/robotic-assisted,”
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“low anterior resection,” “robotic⁄robotic-assisted versus
laparoscopic rectal resection,” and “robotic/robotic-
assisted versus laparoscopic low anterior resection.”
Study selection and quality assessment
Two authors (SYL and XHR) obtained full-text articles
of relevant studies and independently determined the
criteria for inclusion. Disagreements between the two
authors were resolved by discussion and consensus. If
the negotiation failed, a third independent author (XZF)
provided an opinion. The quality of RCTs was evaluated
using the Cochrane Reviewer’s Handbook Jadad scale
[8], and the quality of the NRCTs was evaluated by the
“Methodological Items for Non-randomized Studies” [9].
Criteria for inclusion and exclusion
The following inclusive criteria were required: (1) ran-
domized or non-randomized studies comparing the clin-
ical and oncologic outcomes of R-LAR and L-LAR; (2) if
the same institution and/or authors reported more than
one study, the higher quality study was included; (3) stud-
ies reported at least one of seven outcomes (operative
time, estimated blood loss, length of hospital stay, conver-
sion rate to open surgery, post-operative complications,
circumferential margin status, and number of lymph
nodes collected); and (4) the definition of the rectal cancer
level should be below the peritoneal reflection.
The exclusion criteria were as follows: (1) the clinical
and oncologic outcomes were not reported clearly; (2)
studies reporting proctectomy for rectal cancer that was
not a low anterior resection, such as an abdominoperi-
neal resection and Hartman procedure; (3) overlaps be-
tween authors or institutions in the published literature;
and (4) studies that lacked control arms.
Statistical analysis
Review Manager software (RevMan, version 5.2) pro-
vided by the Cochrane Collaboration was used to per-
form the meta-analysis. Continuous variables were
pooled using the mean difference (MD) with a 95 % con-
fidence interval (CI), and dichotomous variables were
pooled using the odds ratio (OR) with a 95 % CI. If con-
tinuous variables were reported as the median with
range, we calculated the means and standard deviations
according to Hozo [10]. Statistical heterogeneity was
evaluated by I2, and heterogeneity was considered high if
the I2 statistic was >50 %. The fixed effects model was
used for studies with low or moderate statistical hetero-
geneity, and the random effects model was used for
studies with high statistical heterogeneity. Sensitivity
analysis was performed by repeating the meta-analysis
on the studies that were excluded.
Results
Eligible studies
Using the search terms, we initially retrieved 168 publi-
cations. After carefully browsing the abstracts and full
texts, eight comparative studies [11–18] met all of the
inclusion criteria and were eligible for meta-analysis.
One comparative study [18] was excluded because it did
not include patient characteristics, thus leaving seven
suitable studies for the meta-analysis (Fig. 1). The seven
studies [11–17] involved a total of 592 patients (324 in
the R-LAR group and 268 in the L-LAR group) (Table 1).
The seven studies included six non-randomized con-
trolled trials (NRCTs) and one randomized controlled
trial (RCT). The characteristics of these seven studies
are listed in Table 1. Of all the studies, two were con-
ducted in the USA [12, 17], three in Korea [11, 13, 14],
one in Italy [15], and one in Turkey [16]. The quality of
all the studies was satisfactory. The results showed that
R-LAR had longer operative times, lower estimated
blood loss, shorter hospital stays, lower overall post-
operative complications, and a significantly faster recov-
ery of bowel function.
Operative time
All of the studies [11–17] reported operative times; the
meta-analysis showed no significant difference between
the two techniques (MD = 28.4; 95 % CI = −3.48, 60.27;
P = 0.08). The random effects model was used because
of the high heterogeneity among studies (I2 = 93 %)
(Fig. 2).
Length of hospital stay
All of the studies [11–17] reported the length of hospital
stay. The meta-analysis showed that R-LAR required a
shorter hospital stay compared with L-LAR (MD= −1.03;
95 % CI = −1.78, −0.28; P = 0.007). The heterogeneity was
high; therefore, a random effects model was utilized (I2 =
78 %) (Fig. 3).
Conversion to open surgery
Six studies [11–16] reported the rate of conversion to
open surgery. The meta-analysis showed that R-LAR had
a lower conversion rate compared with L-LAR (OR = 0.07;
95 % CI = 0.02, 0.31; P = 0.0004) with no observed hetero-
geneity (I2 = 0 %) (Fig. 4).
Number of harvested lymph nodes
Six studies [11–16] reported the number of harvested
lymph nodes. The meta-analysis showed no significant
difference between the two techniques (MD = −0.63;
95 % CI = −0.78, 2.05; P = 0.38) with no observed hetero-
geneity (I2 = 0 %) (Fig. 5).
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Positive circumferential resection margin involvement
Four studies [11, 14, 15, 17] reported the status of the
circumferential resection margin (CRM). Circumferen-
tial resection margin involvement was found to be sig-
nificantly lower in the R-LAR group than in the L-LAR
group (OR = 0.5; 95 % CI = 0.25, 1.01; P = 0.05) with low
heterogeneity (I2 = 39 %) (Fig. 6).
Post-operative complications
All of the studies [11–17] reported the overall post-
operative complication rate. The result of the meta-
analysis showed that the overall complication rate was
significantly lower in the RRC group (MD = 0.65; 95 %
CI = 0.43, 0.99; P = 0.04) with no heterogeneity (I2 = 0 %)
(Fig. 7).
Fig. 1 Flow diagram of study selection for meta-analysis
Table 1 Characteristics of the eight selected studies included in the meta-analysis
Study Country Group Patients Mean Mean Sex CRT Study Anastomosis
Age BMI M/F (%) Type Technique
Park (2015) [11] Korea RCC 133 59.2 23.1 86:47 11.3 R Hybrid
LRC 84 63.5 22.9 60:24 11.9
Pigazzi (2006) [12] USA RCC 6 60.0 31.0 2:4 33.0 PNR Total/hybrid
LRC 6 70.0 27.0 4:2 33.0
Baik (2008) [13] Korea RCC 18 57.3 22.8 14:4 NS RCT Hybrid
LRC 18 62.0 24.0 14:4 NS
Baik (2009) [14] Korea RCC 56 60.3 23.4 37:19 8.9 PNR Hybrid
LRC 57 63.2 23.2 34:23 12.3
Annibale (2013) [15] Italy RCC 50 66.0 NS 30:20 68.0 PNR Total
LRC 50 65.7 NS 30:20 56.0
Erguner (2013) [16] Turkey RCC 27 54.0 28.3 14:13 14.8 R Total
LRC 37 61.5 26.7 20:17 8.0
Marecik (2011) [17] USA RCC 34 60.0 28.5 20:14 58.8 PNR Hybrid
LRC 24 64.0 25.9 14:10 41.7
Shin (2012) [18] Korea RCC 30 58.1 22.0 18:12 NS PNR Total/hybrid
LRC 30 63.3 20.0 18:12 NS
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Days to return of bowel function
Three studies [11, 13, 14] reported the number of
days to passing flatus. The meta-analysis showed no
significant difference between the two techniques
(MD = −0.15; 95 % CI = −0.37, 0.06; P = 0.17) with no
observed heterogeneity (I2 = 23 %) (Fig. 8).
Discussion
Laparoscopic colorectal surgery was first reported by Ja-
cobs in 1991 [19] and has increasingly become a popular
approach for colorectal procedures. The long-term out-
comes of laparoscopic colorectal surgery have been
shown to be similar to open techniques; however, lapar-
oscopy offers better short-term outcomes [20, 21]. Some
of the advantages of the laparoscopic colorectal tech-
nique over the open procedures include smaller inci-
sions, reduction in post-operative pain and duration of
ileus, quicker post-operative recovery, and earlier return
to normal activity [22]. The new meta-analysis indicates
that laparoscopy benefits rectal cancer patients with a
shorter hospital stay, earlier return of bowel function, re-
duced blood loss and number of blood transfusions and
lower rates of abdominal post-operative bleeding, late in-
testinal adhesion obstruction, and other late morbidities
[23]. The laparoscopic technique still has several limita-
tions, such as tremor, loss of three-dimensional view,
poor ergonomics, and limited dexterity of movement
due to the fixed instrument tips [24]. The da Vinci Sur-
gical System has overcome these limitations and pro-
vides a three-dimensional, high-definition operative field,
the steady “traction and counter-traction,” reduces the
physiologic tremor, and enables three extra degrees of
movement using articulated instruments. However, the
da Vinci Surgical System also has drawbacks, such as the
loss of haptic feedback, limited range of movement of
the robotic arms, time-consuming, and high cost of the
system. Several studies [11, 25–27] have compared the
clinical and oncologic safety and efficacy of robotic re-
section and laparoscopic rectal resection for cancer, but
no meta-analyses have compared R-LAR with conven-
tional L-LAR. Indeed, this is the first meta-analysis com-
paring the two approaches.
Although it is better to use RCTs to perform a meta-
analysis, randomization is difficult to carry out in
Fig. 2 Robotic compared with laparoscopic low anterior resection for cancer: operative time
Fig. 3 Robotic compared with laparoscopic low anterior resection for cancer: length of hospital stay
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surgery. Therefore, NRCTs represent an acceptable alter-
native when performing a meta-analysis comparing two
surgical techniques. We selected studies that we deemed
to be of the highest methodological quality; however, se-
lection bias may have existed because most of the stud-
ies were non-randomized and pre-operative baseline
characteristics were not equal in the included studies.
High heterogeneity for some outcomes may have influ-
enced the effect of the meta-analysis; however, the sig-
nificant impact of factors other than the surgical method
affects these outcomes.
The heterogeneity of the length of hospital stay variable
was high between studies (I2 = 78 %). The reason for the
high heterogeneity between the groups may be differences
in discharge criteria from hospital or different post-
operative complications. The three-dimensional, high-
definition field of view and augmented dexterity offered
by the robotic approach minimizes the risk of injury
of tissue and small blood vessels and leads to fewer
complications, which may be related to the shorter
length of hospital stay. Recently, a systematic review
and meta-analysis about possible benefits of robotic
surgery regarding urinary and sexual dysfunctions was
reported [28], although there were few data and no
randomized controlled trials support the results.
Looking forward to the future randomized controlled
trials could compare this area.
Operative time is considered to be long in robotic
colorectal surgery because of additional set-up time,
additional docking time, and the steep learning curve as-
sociated with this technique [29]. This meta-analysis
showed no significant difference in operative time be-
tween the two surgical approaches. The heterogeneity in
operative time between the two methods was very high
(I2 = 93 %). The set-up time was excluded in all of the
studies. The reasons for high heterogeneity of operative
time are as follows. (1) Some studies adopt hybrid ro-
botic approaches, while some studies adopt full robotic
approaches. (2) Specimen-retrieval techniques (natural
orifice or mini-laparotomy) are different. (3) The learn-
ing curve in R-LAR is less steep than that in L-LAR
procedures, and surgeons are relatively unskilled in the
Fig. 4 Robotic compared with laparoscopic low anterior resection for cancer: length of hospital stay
Fig. 5 Robotic compared with laparoscopic low anterior resection for cancer: number of harvested lymph nodes
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R-LAR technique [30]. As surgeons become more and
more adept with the technique, the operative time for R-
LAR will decrease.
Local recurrence of rectal cancer after surgery is
common and influences survival, and most studies in-
volving CRM focus on local recurrence [31]. The
CRM is a powerful prognostic factor for rectal cancer
resection. In our study, R-LAR was associated with a
lower conversion rate, lower rate of circumferential
margin involvement, and lower overall complication
rate. These findings may be explained by the advan-
tages of the robotic surgical system, including the
three-dimensional operative field, reduction of the
physiologic tremor, and the three extra degrees of
freedom in movement. In combination, these features
may minimize the risk of tissue and vascular injuries.
Local recurrence rate, incision recurrence rate, and
overall recurrence rate are the key to the success or
failure of surgery. In our meta-analysis, few studies
focus on the comparison of post-operative recurrence,
and it was difficult to perform subgroup analyses. We
hope that more randomized controlled studies will be
able to compare the post-operative recurrence rate in
the future.
The major drawback of robotic surgery for rectal can-
cer is the cost. Initial purchasing costs, maintenance
costs, and equipment costs contribute to the high price.
We cannot carry out a comparative analysis of cost
because few studies provide related data. A cost-
effectiveness analysis should be performed before this
approach is widely implemented. Hottenrott [32] re-
ported that the cost may be reduced by increasing prod-
uctivity and competition. Therefore, this drawback may
be overcome as the robotic approach becomes more
widely used.
Our meta-analysis had some limitations. First, the
meta-analysis only included one RCT and six NRCTs.
The latter can bias the interpretation of the results, al-
though the quality of the studies was deemed satisfac-
tory [33]. Second, the number of studies and patients
was relatively small, making it difficult to perform a sub-
group analysis. Finally, matching patient characteristics
is difficult in all of the studies, thus there is still some
heterogeneity in the two groups.
Fig. 6 Robotic compared with laparoscopic low anterior resection for cancer: positive circumferential resection margin involvement
Fig. 7 Robotic compared with laparoscopic low anterior resection for cancer: post-operative overall complications
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Conclusions
This meta-analysis suggests that R-LAR is associated
with a shorter hospital stay, lower conversion rate, lower
rate of circumferential margin involvement, and lower
overall complication rate than L-LAR. There were no
differences in operative time, the number of lymph
nodes removed, and the number of days to return of
bowel function. At present, there are larger randomized
controlled trials (trial ROLARR) comparing robotic ver-
sus laparoscopic rectal resection, and we hope to have
more randomized controlled studies comparing robotic
and laparoscopic low anterior resection.
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